Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513107

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+59,612
Put/Call ratio
30%
SEC-reported price per share
$14.36
Number of holders
148
Value change
-$3,128,334
Number of buys
80
Open additional details 1 more signal available
Number of sells
60
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,606,000

Security key

046513107

Report period

Q1 2021

Institutions

148

Top holders

10

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAUPOST GROUP LLC/MA
Disclosed value leader
BAUPOST GROUP LLC/MA
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $178,809,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAUPOST GROUP LLC/MA has the largest disclosed position value at $178.81M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAUPOST GROUP LLC/MA's linked filing trail.
Disclosed position value Top 5
BAUPOST GROUP LLC/MA $178.81M
MAVERICK CAPITAL LTD $143.78M
Redmile Group, LLC $134.72M
BlackRock Finance, Inc. $126.7M
JPMORGAN CHASE & CO $121.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAUPOST GROUP LLC/MA
13F
Company
13F
—
denominator unverified
$178,809,000
9,108,988 shares
— 31 Dec 2020
MAVERICK CAPITAL LTD
13F
Company
13F
—
denominator unverified
$143,781,000
7,324,539 shares
— 31 Dec 2020
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$134,722,000
6,863,070 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$126,700,000
6,454,415 shares
— 31 Dec 2020
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$121,858,000
6,207,767 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$110,680,000
5,638,274 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
148
Shares
85,650,758
Rows available
148
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q1 2021 holders
148
Holder diff
147
Investor Q1 2026 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2026 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .